Alembic Ltd Share Price

(ALEMBICLTD)

Alembic Ltd is one of India's most experienced manufactures of bulk drugs, pharmaceuticals, and formulations in human and animal healthcare. With a 100-year legacy of operations, they are committed to continually improving the quality of life and healthcare in over 75 countries worldwide. The ISO9002 and ISO14001 certified company manufacturing practices and facilities follow WHOGMP guidelines. Their product range include medicines, chemicals, bulk drugs such as penicillin, other antibiotics, and formulations. With factories in Vadodara, Gujarat, and Solan, Himachal Pradesh, the company has seen tremendous success over the years. From establishing a penicillin plant in 1961, launching of the top selling Erythromycin brand Althrocin in 1972 to manufacturing Cephalosporin C in 2001, Zero - a new generation no calories Sucralose Based Sugar Substitute in 2005, and setting up a formulation manufacturing facility in Baddi with a capacity of 900 million tablets and 600 liquid oral bottles in 2017, Alembic Ltd and its offerings have grown exponentially. Last year, the company acquired the Non-Oncology Business of Dabur Pharma Ltd and entered into a licensing agreement with UCB Belgium while adding new API facilities.

Revenue: ₹57.92Cr as on December 2024 (Q4 24)
Net Profit: ₹26.09Cr as on December 2024 (Q4 24)
Listing date: 04 Jan, 1995
Chairperson Name: Chirayu R Amin